Compounds and compositions for treating conditions associated with LPA receptor activity
AssigneeLhotse Bio, Inc.
InventorsWei Huang, Hui Lei, Zhongmiao Xu, Haizhen Zhang, Qiong Zhang
Life of this patent
Estimating the term…
Abstract
The present disclosure provides LPA antagonists, as well as pharmaceutical compositions comprising the compounds disclosed herein. Also provided are methods for treating LPA-associated diseases, disorders, and conditions.
Claims34
A compound which is:
- or a pharmaceutically acceptable salt thereof.
A compound which is:
- or a pharmaceutically acceptable salt thereof.
A compound, which is:
- or a pharmaceutically acceptable salt thereof.
A compound, which is:
- or a pharmaceutically acceptable salt thereof.
A compound, which is:
- or a pharmaceutically acceptable salt thereof.
A compound, which is:
- or a pharmaceutically acceptable salt thereof.
A compound, which is:
- or a pharmaceutically acceptable salt thereof.
A compound, which is:
- or a pharmaceutically acceptable salt thereof.
A compound, which is:
- or a pharmaceutically acceptable salt thereof.
A compound, which is:
- or a pharmaceutically acceptable salt thereof.
A compound, which is:
- or a pharmaceutically acceptable salt thereof.
A compound, which is:
- or a pharmaceutically acceptable salt thereof.
A compound, which is:
A compound, which is:
A compound, which is:
A compound, which is:
A compound, which is:
A compound, which is:
A compound, which is:
A compound, which is:
A compound, which is:
A compound, which is:
Dependencies are inferred from the claim text.